BioNTech received the M&A Award 2024 in the category “M&A for a Greater Good” for the acquisition of InstaDeep, a leading AI-based technology company, to strengthen its drug discovery and development capabilities. The jury recognized the strategic focus on social and scientific goals as well as the successful integration of InstaDeep, which sustainably strengthens BioNTech’s innovative power.
